{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2020"],"data_sharing_plan":["IPD Sharing (as of March 2023): No"],"condition":["Adenocarcinoma","Neoplasm Metastasis","Gastroesophageal Junction Adenocarcinoma","Esophageal Neoplasms","Neoplasms, Second Primary","Melanoma","Colorectal Cancer","Gastric Cancer","Colorectal Neoplasms","Stomach Neoplasms","Metastatic Cancer","Neoplasms"],"disease":["Adenocarcinoma","Neoplasm Metastasis","Gastroesophageal Junction Adenocarcinoma","Esophageal Neoplasms","Neoplasms, Second Primary","Melanoma","Colorectal Cancer","Gastric Cancer","Colorectal Neoplasms","Stomach Neoplasms","Metastatic Cancer","Neoplasms"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2325451"],"location":["United States"],"study_start_month":["1"],"keyword":["CRC-MSS","GEJ Adenocarcinoma","VE800","Nivolumab","Opdivo","BMS","Vancomycin","Vedanta"],"repository":["ECRIN MDR"],"study_status":["Completed"],"additional_accession":[]},"is_claimable":false,"name":"Study of VE800 and Nivolumab in Patients With Selected Types of Advanced or Metastatic Cancer","description":"This study evaluated the safety and efficacy of VE800 in combination with nivolumab in patients with selected types of advanced or metastatic cancer","dates":{"creation":"2020-01-15"},"accession":"2325451","cross_references":{"ClinicalTrials___gov":["NCT04208958"]}}